Amgen Inc (AMGN)
315.29
-3.75
(-1.18%)
USD |
NASDAQ |
May 16, 15:25
Amgen Price to Book Value: 33.68 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 15, 2024 | 34.08 |
May 14, 2024 | 33.26 |
May 13, 2024 | 32.95 |
May 10, 2024 | 33.13 |
May 09, 2024 | 33.42 |
May 08, 2024 | 32.83 |
May 07, 2024 | 32.08 |
May 06, 2024 | 31.99 |
May 03, 2024 | 33.25 |
May 02, 2024 | 29.74 |
May 01, 2024 | 29.63 |
April 30, 2024 | 29.26 |
April 29, 2024 | 29.52 |
April 26, 2024 | 28.84 |
April 25, 2024 | 28.77 |
April 24, 2024 | 29.16 |
April 23, 2024 | 29.22 |
April 22, 2024 | 29.04 |
April 19, 2024 | 28.72 |
April 18, 2024 | 28.06 |
April 17, 2024 | 28.20 |
April 16, 2024 | 28.37 |
April 15, 2024 | 28.36 |
April 12, 2024 | 28.55 |
April 11, 2024 | 28.84 |
Date | Value |
---|---|
April 10, 2024 | 28.46 |
April 09, 2024 | 28.88 |
April 08, 2024 | 28.75 |
April 05, 2024 | 28.83 |
April 04, 2024 | 28.63 |
April 03, 2024 | 29.31 |
April 02, 2024 | 29.50 |
April 01, 2024 | 30.23 |
March 31, 2024 | |
March 28, 2024 | 24.45 |
March 27, 2024 | 24.62 |
March 26, 2024 | 24.23 |
March 25, 2024 | 24.15 |
March 22, 2024 | 23.75 |
March 21, 2024 | 23.82 |
March 20, 2024 | 23.48 |
March 19, 2024 | 23.37 |
March 18, 2024 | 23.30 |
March 15, 2024 | 23.12 |
March 14, 2024 | 23.35 |
March 13, 2024 | 23.73 |
March 12, 2024 | 23.78 |
March 11, 2024 | 23.68 |
March 08, 2024 | 23.54 |
March 07, 2024 | 23.46 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
9.387
Minimum
May 31 2019
149.73
Maximum
May 31 2022
26.59
Average
15.81
Median
Price to Book Value Benchmarks
Johnson & Johnson | 5.292 |
Eli Lilly and Co | 57.43 |
Merck & Co Inc | 8.217 |
Pfizer Inc | 1.776 |
Vertex Pharmaceuticals Inc | 6.119 |
Price to Book Value Related Metrics
PE Ratio | 45.04 |
PS Ratio | 5.736 |
Price to Free Cash Flow | 23.86 |
Price | 315.29 |
Earnings Yield | 2.22% |
Market Cap | 169.13B |
Operating PE Ratio | 24.31 |
Normalized PE Ratio | 45.04 |